10/07/2014 - 9:04am

Omron Healthcare on Tuesday introduced a new line of monitors that provide even more accurate results, according to the company. 

10/06/2014 - 11:43am

Mylan announced the launch of its lamivudine and zidovudine tablets USP, in 150-mg dosage strength.

10/06/2014 - 10:09am

UrgentRx on Monday announced the expansion of its product line to include UrgentRx Fast Powders 10-count multipack boxes of its single-dose packets for a variety of common ailments. 

10/01/2014 - 11:01am

Ranbaxy Labs on Wednesday announced the launch of Absorica (isotretinoin) 25 mg and 35 mg capsules into the U.S. healthcare market. 

09/30/2014 - 1:47pm

Par Pharmaceutical on Tuesday announced that it has started shipping amlodipine and valsartan tablets in all four dosage strengths.

09/30/2014 - 12:55pm

Salix Pharmaceuticals and Progenics Pharmaceuticals announced that the Food and Drug Administration approved Relistor (methylnaltrexone bromide) subcutaneous injection in 12-mg dosage strength to treat constipation in patients taking opioids for chronic, non-cancer pain. 

09/26/2014 - 2:25pm

Boehringer Ingelheim Pharmaceuticals announced that the Food and Drug Administration approved Spiriva Respimat (tiotropium bromide) inhalation spray as a treatment for bronchospasm associated with chronic obstructive pulmonary disease. 

09/26/2014 - 11:37am

Camber Pharmaceuticals announced the launch of raloxifene hydrochloride, USP tablets in 60-mg dosage strengths.

09/25/2014 - 12:17pm

AbbVie on Thursday announced that the Food and Drug Administration approved Humira (adalimumab) as a treatment for pediatric Crohn's disease patients ages 6 years and older when other treatments haven't worked well enough.